Wellbutrin
NDC Package 64455-730-07

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Wellbutrin is a medication used to treat depression. Marketed by Bta Pharmaceuticals, this product is identified by NDC 64455-730 and is authorized under FDA application NDA021515.

Identification & Billing

NDC Package Code
64455-730-07
Package Description
7 TABLET, EXTENDED RELEASE in 1 BOTTLE
Product Code
64455-730
11-Digit Billing Format
64455073007

Clinical Specifications

Proprietary Name
Wellbutrin XL
Dosage Form
-
Usage Information
This medication is used to treat depression. It may also be used to prevent seasonal affective disorder (SAD), a type of depression that occurs each year at the same time (for example, during winter). This medication can improve your mood and feelings of well-being. It may work by restoring the balance of certain natural substances (dopamine, norepinephrine) in the brain.

Regulatory & Marketing

Labeler Name
Bta Pharmaceuticals
FDA Application #
NDA021515
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-23-2009
End Marketing Date
10-31-2013
Listing Expiration
10-31-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (64455-730). Click a package code to view its specific billing and regulatory data.

64455-730-30
30 TABLET, EXTENDED RELEASE in 1 BOTTLE
64455-730-90
90 TABLET, EXTENDED RELEASE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64455-730-07 identifies a specific commercial package of 7 tablet, extended release in 1 bottle of Wellbutrin XL, labeled by Bta Pharmaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Bta Pharmaceuticals on December 23, 2009. The current certification is valid through October 31, 2013.

What are the primary indications for this medication?

This medication is used to treat depression. It may also be used to prevent seasonal affective disorder (SAD), a type of depression that occurs each year at the same time (for example, during winter). This medication can improve your mood and feelings of well-being. It may work by restoring the balance of certain natural substances (dopamine, norepinephrine) in the brain.

How is this Bta Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64455073007. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
64455-730-07
11-Digit CMS (5-4-2)
64455-0730-07

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.